By Emeritus Professor Michael Barton

Journal articles

Jaffray DA; Knaul FM; Atun R; Adams C; Barton MB; Baumann M; Lievens Y; Lui TYM; Rodin DL; Rosenblatt E; Torode J; van Dyk J; Vikram B; Gospodarowicz M, 2015, 'Global Task Force on Radiotherapy for Cancer Control', Lancet Oncology, 16, pp. 1144 - 1146, http://dx.doi.org/10.1016/S1470-2045(15)00285-5

Kang YJ; O'Connell DL; Tan J; Lew JB; Demers A; Lotocki R; Kliewer EV; Hacker NF; Jackson M; Delaney GP; Barton M; Canfell K, 2015, 'Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities', Cancer Epidemiology, 39, pp. 600 - 611, http://dx.doi.org/10.1016/j.canep.2015.04.009

Rosenblatt E; Barton M; Mackillop W; Fidarova E; Cordero L; Yarney J; Lim G; Abad A; Cernea V; Stojanovic-Rundic S; Strojan P; Kobachi L; Quarneti A, 2015, 'Optimal radiotherapy utilisation rate in developing countries: An IAEA study', Radiotherapy and Oncology, 116, pp. 35 - 37, http://dx.doi.org/10.1016/j.radonc.2015.06.012

Borras JM; Barton M; Grau C; Corral J; Verhoeven R; Lemmens V; Van Eycken L; Henau K; Primic-Zakelj M; Strojan P; Trojanowski M; Dyzmann-Sroka A; Kubiak A; Gasparotto C; Defourny N; Malicki J; Dunscombe P; Coffey M; Lievens Y, 2015, 'The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project', Radiotherapy and Oncology, 116, pp. 45 - 50, http://dx.doi.org/10.1016/j.radonc.2015.04.021

Borras JM; Lievens Y; Dunscombe P; Coffey M; Malicki J; Corral J; Gasparotto C; Defourny N; Barton M; Verhoeven R; Van Eycken L; Primic-Zakelj M; Trojanowski M; Strojan P; Grau C, 2015, 'The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis', Radiotherapy and Oncology, 116, pp. 38 - 44, http://dx.doi.org/10.1016/j.radonc.2015.04.018

Sitas F; Yap S; Egger S; Christian K; Hodgkinson V; Barton M; Banks E; Canfell K; O'Connell DL; Nair-Shalliker V, 2015, 'The Cancer, Lifestyle and Evaluation of Risk Study (CLEAR): Rationale and design of an unmatched "case-spouse control" study of over 10,000 participants in New South Wales, Australia', Cancer Epidemiology, 39, pp. 414 - 423, http://dx.doi.org/10.1016/j.canep.2015.03.006

Petrushevski AN; Gabriel GS; Hanna TP; Allen S; Allison RW; Barton MB, 2015, 'Factors affecting the use of single-fraction radiotherapy for the palliation of bone metastases in Australia', Clinical Oncology, 27, pp. 205 - 212, http://dx.doi.org/10.1016/j.clon.2014.11.027

Hanna TP; Shafiq J; Delaney GP; Barton MB, 2015, 'The population benefit of radiotherapy for cervical cancer: Local control and survival estimates for optimally utilized radiotherapy and chemoradiation', Radiotherapy and Oncology, 114, pp. 389 - 394, http://dx.doi.org/10.1016/j.radonc.2015.02.005

Delaney GP; Barton MB, 2015, 'Evidence-based Estimates of the Demand for Radiotherapy', Clinical Oncology, 27, pp. 70 - 76, http://dx.doi.org/10.1016/j.clon.2014.10.005

Jaffray DA; Atun R; Barton M; Baumann M; Gospodarowicz M; Hoskin P; Knaul FM; Lievens Y; Rosenblatt E; Torode J; Van Dyk J; Vikram B, 2015, 'Radiation Therapy and the Global Health Agenda', Clinical Oncology, 27, pp. 67 - 69, http://dx.doi.org/10.1016/j.clon.2014.11.025

Ng W; Jacob S; Delaney G; Do V; Barton M, 2015, 'Estimation of an optimal chemotherapy utilisation rate for upper gastrointestinal cancers: Setting an evidence-based benchmark for the best-quality cancer care', Gastroenterology Research and Practice, 2015, http://dx.doi.org/10.1155/2015/753480

Wong K; Delaney GP; Barton MB, 2015, 'Estimation of the optimal number of radiotherapy fractions for breast cancer: A review of the evidence', Radiotherapy and Oncology, 116, pp. 174 - 178, http://dx.doi.org/10.1016/j.radonc.2015.07.015

Thompson SR; Delaney GP; Gabriel GS; Barton MB, 2015, 'Patterns of care study of brachytherapy in New South Wales: Malignancies of the uterine corpus', Journal of Contemporary Brachytherapy, 7, pp. 224 - 230, http://dx.doi.org/10.5114/jcb.2015.52623

Do V; Jacob S; Ng W; Delaney GP; Barton MB, 2015, '120PD An estimation of the population-based survival benefit of first-line chemotherapy for adult primary malignant brain tumour', Annals of Oncology, 26, pp. ix34 - ix34, http://dx.doi.org/10.1093/annonc/mdv520.04

Do V; Ng W; Jacob S; Delaney G; Barton M, 2015, 'An Estimation of the Population-Based Survival Benefit of First-Line Chemotherapy for Lung Cancer', Annals of Oncology, 26, pp. i29 - i29, http://dx.doi.org/10.1093/annonc/mdv050.37

Borras JM; Dunscombe P; Barton M; Gasparotto C; Defourny N; Grau C; Lievens Y, 2015, 'ASSESSING THE GAP BETWEEN EVIDENCE BASED INDICATIONS FOR RADIOTHERAPY AND ACTUAL PRACTICE IN EUROPEAN COUNTRIES', VALUE IN HEALTH, 18, pp. A481 - A482, http://dx.doi.org/10.1016/j.jval.2015.09.1311

Rosenblatt E; Barton M; Mackillop W; Fidarova E; Cordero L; Yarney J; Lim CC; Abad A; Cernea V; Stojanovic-Rundic S; Strojan P; Kochbati L; Quarneti A, 2015, 'OC-0192: Optimal radiotherapy utilization rate in developing countries: an IAEA study', Radiotherapy and Oncology, 115, pp. S96 - S97, http://dx.doi.org/10.1016/s0167-8140(15)40190-2

Rosenblatt E; Fidarova E; Utehina O; Tkachev S; Kislyakova M; Semikoz N; Sinaika V; Kim V; Karamyan N; Isayev I; Akbarov K; Lomidze D; Bondareva O; Tuzlukov P; Zardodkhonova M; Alimov J; Jones GW; Barton M; Mackillop W, 2015, 'OC-0193: Current radiotherapy capacity in post-Soviet countries; an IAEA survey', Radiotherapy and Oncology, 115, pp. S97 - S98, http://dx.doi.org/10.1016/s0167-8140(15)40191-4

Thompson SR; Delaney GP; Gabriel GS; Izard MA; Hruby G; Jagavkar R; Bucci J; Barton MB, 2014, 'Prostate brachytherapy in New South Wales: Patterns of care study and impact of caseload on treatment quality', Journal of Contemporary Brachytherapy, 6, pp. 344 - 349, http://dx.doi.org/10.5114/jcb.2014.46610

Do V; Ng W; Delaney G; Barton M, 2014, '606PAN ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR GASTROINTESTINAL CANCER.', Ann Oncol, 25, pp. iv206 - iv207, http://dx.doi.org/10.1093/annonc/mdu333.107

Barton MB; Jacob S; Shafiq J; Wong K; Thompson SR; Hanna TP; Delaney GP, 2014, 'Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012', Radiotherapy and Oncology, 112, pp. 140 - 144, http://dx.doi.org/10.1016/j.radonc.2014.03.024

Thompson SR; Delaney GP; Gabriel GS; Barton MB, 2014, 'Patterns of care study of brachytherapy in New South Wales: Cervical cancer treatment quality depends on caseload', Journal of Contemporary Brachytherapy, 6, pp. 28 - 32, http://dx.doi.org/10.5114/jcb.2014.42022

Barton MB; Allen S; Delaney GP; Hudson HM; Hao Z; Allison RW; van der Linden YM, 2014, 'Patterns of Retreatment by Radiotherapy', Clinical Oncology, 26, pp. 611 - 618, http://dx.doi.org/10.1016/j.clon.2014.03.008

Keall PJ; Barton M; Crozier S, 2014, 'The Australian Magnetic Resonance Imaging-Linac Program', Seminars in Radiation Oncology, 24, pp. 203 - 206, http://dx.doi.org/10.1016/j.semradonc.2014.02.015

Windsor AA; Koh ES; Allen S; Gabriel GS; Yeo AET; Allison R; van der Linden YM; Barton MB, 2013, 'Poor outcomes after whole brain radiotherapy in patients with brain metastases: Results from an international multicentre cohort study', Clinical Oncology, 25, pp. 674 - 680, http://dx.doi.org/10.1016/j.clon.2013.07.002

Kenny LM; Peters LJ; Barton M; Milross C, 2013, 'Radiotherapy - A leap forward in cancer care', Cancer Forum, 37, pp. 42 - 46

Thompson SR; Delaney GP; Gabriel GS; Jacob SA; Barton MB, 2013, 'Estimation of the optimal brachytherapy utilization rate in the treatment of gynecological cancers and comparison with patterns of care', International Journal of Radiation Oncology and Biology Physics, 85, pp. 400 - 405, http://dx.doi.org/10.1016/j.ijrobp.2012.04.014

Barton MB; Shafiq RJ; Jacob S; Wong K; Delaney GP; Hanna TP, 2013, 'OC-0367: New evidence-based benchmarks for radiotherapy service provision', Radiotherapy and Oncology, 106, pp. S143 - S144, http://dx.doi.org/10.1016/s0167-8140(15)32673-6

Spigelman AD; Pascoe S; Harris MF; Beilby J; Crossland LJ; Gett R; Barton MB; Jayasinghe UW, 2013, 'Referral pathways in colorectal cancer: An audit of surgeons records', Australian Health Review, http://dx.doi.org/10.1071/AH13038

Metcalfe P; Liney G; Holloway L; Walker AM; Barton MB; Delaney GP; Vinod SK; Tome W; Walker A; Walker A, 2013, 'The potential for an enhanced role for MRI in radiation-therapy treatment planning', Technology in Cancer Research and Treatment, 12, pp. 429 - 446, http://dx.doi.org/10.7785/tcrt.2012.500342

Goldsbury D; Harris MF; Pascoe S; Barton MB; Olver I; Spigelman AD; Beilby J; Veitch C; Weller D; O Connell DL, 2013, 'The varying role of the GP in the pathway between colonoscopy and surgery for colorectal cancer: a retrospective cohort study', BMJ Open, 3, pp. 1 - 13, http://dx.doi.org/10.1136/bmjopen-2012-002325

Fong A; Shafiq J; Saunders C; Thompson A; Tyldesley S; Olivotto IA; Barton MB; Dewar J; Jacob SA; Ng W; Speers CH; Delaney GP, 2012, 'A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of "optimal" therapy', Breast, 21, pp. 570 - 577, http://dx.doi.org/10.1016/j.breast.2012.02.014

Shafiq J; Saunders C; Thompson A; Tyldesley S; Olivotto IA; Barton MB; Dewar J; Ng W; Speers CH; Delaney GP, 2012, 'A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy', Breast, 21, pp. 562 - 569, http://dx.doi10.1016/j.breast.2012.01.006

Thompson SR; Delaney GP; Gabriel GS; Jacob S; Barton MB, 2012, 'Estimation of the optimal brachytherapy utilisation rate in the treatment of vaginal cancer and comparison with patterns of care', Journal of medical imaging & radiation oncology, 56, pp. 483 - 489, http://dx.doi.org/10.1111/j.1754-9485.2012.02392.x

Goldsbury D; Harris MF; Pascoe S; Olver I; Barton M; Spigelman AD; O''connell D, 2012, 'Socio-demographic and other patient characteristics associated with time between colonoscopy and surgery, and choice of treatment centre for colorectal cancer: a retrospective cohort study', BMJ Open, 2, pp. e001070, http://dx.doi.org/10.1136/bmjopen-2012-001070

Blinman P; Grimison PS; Barton MB; Crossing S; Walpole ET; Wong N; Francis K; Koczwara B, 2012, 'The shortage of medical oncologists: The Australian medical oncologist workforce study', Medical Journal of Australia, 196, pp. 58 - 61, http://dx.doi.org/10.5694/mja11.10363

Koczwara B; Barton MB; Walpole E; Grimison PS; Blinman P; Crossing S; Francis K, 2012, 'Workforce shortages in medical oncology: A looming threat to quality cancer care', Medical Journal of Australia, 196, pp. 32 - 33, http://dx.doi.org/10.5694/mja11.10356

Jacob S; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an Optimal Chemotherapy Utilisation Rate for Primary Malignant Brain Tumours: an Evidence-based Benchmark for Cancer Care', CLINICAL ONCOLOGY, 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011

Barton MB; Delaney GP, 2011, 'A decade of investment in radiotherapy in New South Wales: Why does the gap between optimal and actual persist?', Journal of Medical Imaging and Radiation Oncology, 55, pp. 411 - 433, http://dx.doi.org/10.1111/j.1754-9485.2011.02292.x

Jacob SA; Ng W; Asghari R; Delaney GP; Barton MB, 2011, 'Chemotherapy in rectal cancer: variation in utilization and development of an evidencebased benchmark rate of optimal chemotherapy utilization', Clinical Colorectal Cancer, 10, pp. 102 - 107, http://dx.doi.org/10.1016/j.clcc.2011.03.005

Jacob SA; Ng W; Delaney GP; Barton MB, 2011, 'Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care', Clinical Oncology, 23, pp. 48 - 54, http://dx.doi.org/10.1016/j.clon.2010.08.011

Christie DL; Dear K; Le T; Barton MB; Writh A; Porter DJ; Roos DE; Pratt G, 2011, 'Limited chemotherapy and shrinking field radiotherapy for osteolymphoma (primary bone lymphoma): Results from the Trans-Tasman radiation oncology group 99.04 and Australasian Leukaemia and lymphoma group LY02 prospective trial', International Journal of Radiation Oncology and Biology Physics, 80, pp. 1164 - 1170, http://dx.doi.org/10.1016/j.ijrobp.2010.03.036

Fong A; Shafiq J; Saunders C; Thompson A; Tyldesley S; Barton MB; Dewar JA; Ng W; Jacob S; Speers C; Olivotto I; Delaney GP, 2010, 'A Comparison of Breast Cancer Treatment Rates in British Columbia, Scotland, and Western Australia, and a Comparison with Models of "Optimal" Therapy', CANCER RESEARCH, 70, http://dx.doi.org/10.1158/0008-5472.SABCS10-123-11-11

Morgan G; Barton MB; Atkinson CH; Millar J; Gogna K; Yeoh E, 2010, '‘GAP’ in radiotherapy services in Australia and New Zealand in 2009', Journal of Medical Imaging and Radiation Oncology, 54, pp. 287 - 297, http://dx.doi.org/10.1111/j.1754-9485.2010.02172.x

Ng W; Jacob SA; Delaney GP; Barton MB, 2010, 'Chemotherapy in Head and Neck Cancers: Summary of Recommendations and a Critical Review of Clinical Practice Guidelines', The European Journal of Clinical and Medical Oncology, 2, pp. 65 - 71

Barton MB; Thode RJ, 2010, 'Distance learning in the applied sciences of oncology', Radiotherapy and Oncology, 95, pp. 129 - 132, http://dx.doi.org/10.1016/j.radonc.2010.02.011

Fong A; Ng W; Barton MB; Delaney GP, 2010, 'Estimation of an evidence-based benchmark for the optimal endocrine therapy utilization rate in breast cancer.', Breast, 19, pp. 345 - 349, http://dx.doi.org/10.1016/j.breast.2010.02.006

Ng W; Delaney GP; Jacob SA; Barton MB, 2010, 'Estimation of an optimal chemotherapy utilisation rate for breast cancer: Setting an evidence-based benchmark for the best quality cancer care.', European Journal of Cancer, 46, pp. 703 - 712

Jacob SA; Hovey E; Ng W; Vinod SK; Delaney GP; Barton MB, 2010, 'Estimation of an optimal chemotherapy utilisation rate for lung cancer: An evidence-based benchmark for cancer care.', Lung Cancer, 69, pp. 307 - 314

Jacob SA; Wong K; Delaney GP; Adams P; Barton MB, 2010, 'Estimation of an optimal utilisation rate for palliative radiotherapy in newly diagnosed cancer patients', Clinical Oncology, 22, pp. 56 - 64

Back to profile page